Key result
Adherence-promoting interventions for cardiovascular medication lacked gender-specific designs in all 11 included studies, with only 2 reporting gender-specific effects of gender-neutral interventions.
Why the study?
Compared to men, women have lower cardiovascular disease treatment rates, higher medication non-adherence risk, and different non-adherence reasons.
Do adherence-promoting interventions have gender-specific effects on cardiovascular medication adherence?
Systematic Review (n=11)
Do adherence-promoting interventions have gender-specific effects on cardiovascular medication adherence?
Most studies addressing cardiovascular medication adherence do not analyze potential differences in effect by gender, and none use gender-specific interventions.
Adherence interventions lack gender-specific effects or design; leaves open whether tailored approaches could improve cardiovascular medication adherence.
BACKGROUND: Compared to men, women have lower treatment rates for cardiovascular disease (CVD), are at higher risk for medication non-adherence and have different reasons for being non-adherent. The aim of this study was to synthesize and evaluate gender-specific adherence-promoting interventions for cardiovascular medication and gender-specific effects of gender-neutral interventions. METHODS: A systematic literature search was performed in PubMed, Embase, PsycINFO, CINAHL and Cochrane Library from January 2007 to October 2019. Intervention studies (with control group) aimed at improving cardiovascular medication adherence with minimally 14 weeks follow-up were included. Two reviewers independently screened titles and abstracts. Full text was obtained for selected abstracts and screened for final inclusion. Data extraction included gender-specific targeting or analysis. RESULTS: The search identified 6502 citations. After screening title and abstract, full text was obtained from 127 potentially eligible articles. Ultimately, 11 articles were included that analyzed gender differences in gender-neutral interventions. Two reported a gender-specific intervention effect. Using an electronic reminder device, one study increased statin adherence in women. The other found a larger increase in adherence to CVD medication following telephone counseling for men than women. Nine studies did not identify a gender-specific effect. CONCLUSION: Despite differences in levels of and reasons for non-adherence, most studies addressing adherence did not analyze potential differences in effect by gender. Moreover, none of the identified studies used gender-specific adherence promoting interventions. Increasing awareness about gender differences in adherence might lead to better tailoring of interventions to gender-specific needs and better results in improving adherence.
No takes yet. Share an insight, caveat, or question.
Vervloet et al. (2020) conducted a systematic review in Cardiovascular disease (n=11). Adherence-promoting interventions vs. Control group was evaluated on Gender-specific intervention effect on medication adherence. Adherence-promoting interventions for cardiovascular medication lacked gender-specific designs in all 11 included studies, with only 2 reporting gender-specific effects of gender-neutral interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: